Table 2.
Detailed information of the postoperative treatment and complication.
| Case number | Radiotherapy or chemotherapy | Postoperative anticoagulant | Postoperative flap-related complication | Postoperative complications |
|---|---|---|---|---|
| 1 | Postop: chemoradiation (External medical record not available) | LMWH 6150AXaIU/day subcutaneous for 8-days | / | Hypoalbuminemia, hypokalemia |
| 2 | / | LMWH 6150AXaIU/day subcutaneous for 7-days | / | Mild facial nerve palsy |
| 3 | Postop: 70 Gy radiation | Enoxaparin 4000AXaIU/day for 1-day | / | Pneumonia |
| 4 | Preop: 60 Gy radiation | / | / | Mild wound infection |
| Postop: paclitaxel + cisplatin + tislelizumab | ||||
| 5 | Preop: paclitaxel + cisplatin + tislelizumab | / | / | / |
| Postop: 72 Gy radiation + paclitaxel + cisplatin | ||||
| 6 | / | / | / | Left facial pneumoderma |
| 7 | / | / | / | / |
| 8 | Postop: chemoradiation (External medical record not available) | LMWH 4100AXaIU/day subcutaneous for 6-days | / | / |
| 9 | Postop: chemoradiation (External medical record not available) | Enoxaparin 4000AXaIU/day for 3-days | / | Venous thrombosis |
| 10 | / | / | Hemorrhage | / |
| 11 | Postop: paclitaxel + cisplatin+70 Gy radiation | LMWH 4100AXaIU/day subcutaneous for 4-days | Hemorrhage | / |
| 12 | Postop: paclitaxel + cisplatin+70 Gy radiation | Enoxaparin 4000AXaIU/day for 3-days; rivaroxaban 15 mg bid | / | / |
| 13 | / | / | / | / |
| 14 | Preop: neoadjuvant tislelizumab | / | Mild purple discoloration of the flap on POD (postoperative day) 4 | Pneumonia |
| 15 | Postop: chemoradiation (External medical record not available) | LMWH 4100AXaIU/day subcutaneous for 5-days | / | / |
| 16 | Postop: 60 Gy radiation | / | / | / |
| 17 | Postop: 70 Gy radiation | LMWH 4100AXaIU/day subcutaneous for 1-day | / | Swollen left arm, blisters |
| 18 | / | / | Pharyngeal fistula on POD3 | / |
| 19 | Postop: 72 Gy radiation | LMWH 6150AXaIU/day subcutaneous for 4-days | Pharyngeal fistula on POD4 | Hypoalbuminemia, pneumonia, pleural effusion |